Cover image for Chemical analysis of antibiotic residues in food
Title:
Chemical analysis of antibiotic residues in food
Publication Information:
Hoboken, NJ. : Wiley & Sons, c2012.
Physical Description:
xxi, 353 p. : ill. ; 29 cm.
ISBN:
9780470490426

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010302989 RA1270.V47 C445 2012 f Open Access Book Book
Searching...

On Order

Summary

Summary

An insightful exploration of the key aspects concerning the chemical analysis of antibiotic residues in food

The presence of excess residues from frequent antibiotic use in animals is not only illegal, but can pose serious health risks by contaminating products for human consumption such as meat and milk. Chemical Analysis of Antibiotic Residues in Food is a single-source reference for readers interested in the development of analytical methods for analyzing antibiotic residues in food. It covers themes that include quality assurance and quality control, antibiotic chemical properties, pharmacokinetics, metabolism, distribution, food safety regulations, and chemical analysis. In addition, the material presented includes background information valuable for understanding the choice of marker residue and target animal tissue to use for regulatory analysis. This comprehensive reference:

Includes topics on general issues related to screening and confirmatory methods

Presents updated information on food safety regulation based on routine screening and confirmatory methods, especially LC-MS

Provides general guidance for method development, validation, and estimation of measurement uncertainty

Chemical Analysis of Antibiotic Residues in Food is written and organized with a balance between practical use and theory to provide laboratories with a solid and reliable reference on antibiotic residue analysis. Thorough coverage elicits the latest scientific findings to assist the ongoing efforts toward refining analytical methods for producing safe foods of animal origin.


Author Notes

JIAN WANG is currently a research scientist leading a research and development unit for the Canadian Food Inspection Agency in Calgary, Alberta. His responsibilities include planning and conducting research projects in method development for antibiotic and pesticide residues in foods using advanced mass spectral analysis techniques such as UPLC/Q-TOF and LC/ESI-MS/MS. He has written over thirty publications for various journals and books. He was most recently awarded the CFIA Science Branch Recognition Award for leading method development on melamine investigation in 2007.

JAMES D. MacNEIL retired as head of the Centre for Veterinary Drug Residues of the Canadian Food Inspection Agency in 2007. His recent achievements include receiving the Joint FAO/WHO Expert Committee on Food Additives 50th Anniversary commemorative silver medal awarded in 2006 for services to JECFA; the Public Service of Canada Award of Excellence, a career achievement in 2007; and appointment as scientist emeritus by CFIA in 2008. He is the former scientific editor for "Drugs, Cosmetics, and Forensics" of the Journal of AOAC International and the author of numerous publications on veterinary drug residue analysis. He is currently an adjunct professor in the Department of Chemistry, Saint Mary's University, Halifax, Canada.

JACK F. KAY works in the UK Department for Environment, Food and Rural Affairs. He helped draft European Commission Decision 2002/657/EC and, in 2008, introduced joint auditing to this and ISO 17025 standards into a major UK laboratory. He has actively participated in the Codex Committee on Residues of Veterinary Drugs in Food for more than ten years and was appointed an expert advisor on honey to the Food and Agriculture Organization of the United Nations in 2008. Since 2005, he has held an Honorary Senior Research Fellowship in the Department of Mathematics and Statistics at the University of Strathclyde, Scotland.


Table of Contents

Philip Thomas ReevesPeter Lees and Pierre-Louis ToutainKevin J. Greenlees and Lynn G. Friedlander and Alistair BoxallAlida A. M. (Linda) Stolker and Martin DanaherSara Stead and Jacques StarkJian Wang and Sherri B. TurnipseedJonathan A. Tarbin and Ross A. Potter and Alida A. M. (Linda) Stolker and Bjorn BerendsenJack F. Kay and James D. MacNeilJian Wang and Andrew Cannavan and Leslie Dickson and Rick FedeniukAndrew Cannavan and Jack F. Kay and Bruno Le Bizec
Prefacep. xv
Acknowledgmentp. xvii
Editorsp. xix
Contributorsp. xxi
1 Antibiotics: Groups and Propertiesp. 1
1.1 Introductionp. 1
1.1.1 Identificationp. 1
1.1.2 Chemical Structurep. 2
1.1.3 Molecular Formulap. 2
1.1.4 Composition of the Substancep. 2
1.1.5 pKap. 2
1.1.6 UV Absorbancep. 3
1.1.7 Solubilityp. 3
1.1.8 Stabilityp. 3
1.2 Antibiotic Groups and Propertiesp. 3
1.2.1 Terminologyp. 3
1.2.2 Fundamental Conceptsp. 4
1.2.3 Pharmacokinetics of Antimicrobial Drugsp. 4
1.2.4 Pharmacodynamics of Antimicrobial Drugsp. 5
1.2.4.1 Spectrum of Activityp. 5
1.2.4.2 Bactericidal and Bacteriostatic Activityp. 6
1.2.4.3 Type of Killing Actionp. 6
1.2.4.4 Minimum Inhibitory Concentration and Minimum Bactericidal Concentrationp. 7
1.2.4.5 Mechanisms of Actionp. 7
1.2.5 Antimicrobial Drug Combinationsp. 7
1.2.6 Clinical Toxicitiesp. 7
1.2.7 Dosage Formsp. 8
1.2.8 Occupational Health and Safety Issuesp. 8
1.2.9 Environmental Issuesp. 8
1.3 Major Groups of Antibioticsp. 8
1.3.1 Aminoglycosidesp. 8
1.3.2 ß-Lactamsp. 10
1.3.3 Quinoxalinesp. 18
1.3.4 Lincosamidesp. 20
1.3.5 Macrolides and Pleuromutilinsp. 21
1.3.6 Nitrofuransp. 27
1.3.7 Nitroimidazolesp. 28
1.3.8 Phenicolsp. 30
1.3.9 Polyether Antibiotics (Ionophores)p. 31
1.3.10 Polypeptides, Glycopeptides, and Streptograminsp. 35
1.3.11 Phosphoglycolipidsp. 36
1.3.12 Quinolonesp. 36
1.3.13 Sulfonamidesp. 44
1.3.14 Tetracyclinesp. 45
1.4 Restricted and Prohibited Uses of Antimicrobial Agents in Food Animalsp. 52
1.5 Conclusionsp. 52
Acknowledgmentsp. 53
Referencesp. 53
2 Pharmacokinetics, Distribution, Bioavailability, and Relationship to Antibiotic Residuesp. 61
2.1 Introductionp. 61
2.2 Principles of Pharmacokineticsp. 61
2.2.1 Pharmacokinetic Parametersp. 61
2.2.2 Regulatory Guidelines on Dosage Selection for Efficacyp. 64
2.2.3 Residue Concentrations in Relation to Administered Dosep. 64
2.2.4 Dosage and Residue Concentrations in Relation to Target Clinical Populationsp. 66
2.2.5 Single-Animal versus Herd Treatment and Establishment of Withholding Time (WhT)p. 66
2.2.6 Influence of Antimicrobial Drug (AMD) Physicochemical Properties on Residues and WhTp. 67
2.3 Administration, Distribution, and Metabolism of Drug Classesp. 67
2.3.1 Aminoglycosides and Aminocyclitolsp. 67
2.3.2 ß-Lactams: Penicillins and Cephalosporinsp. 69
2.3.3 Quinoxalines: Carbadox and Olaquindoxp. 71
2.3.4 Lincosamides and Pleuromutilinsp. 71
2.3.5 Macrolides, Triamilides, and Azalidesp. 72
2.3.6 Nitrofuransp. 73
2.3.7 Nitroimidazolesp. 73
2.3.8 Phenicolsp. 73
2.3.9 Polyether Antibiotic Ionophoresp. 74
2.3.10 Polypeptidesp. 75
2.3.11 Quinolonesp. 75
2.3.12 Sulfonamides and Diaminopyrimidinesp. 77
2.3.13 Polymyxinsp. 79
2.3.14 Tetracyclinesp. 79
2.4 Setting Guidelines for Residues by Regulatory Authoritiesp. 81
2.5 Definition, Assessment, Characterization, Management, and Communication of Riskp. 82
2.5.1 Introduction and Summary of Regulatory Requirementsp. 82
2.5.2 Risk Assessmentp. 84
2.5.2.1 Hazard Assessmentp. 88
2.5.2.2 Exposure Assessmentp. 89
2.5.3 Risk Characterizationp. 90
2.5.4 Risk Managementp. 91
2.5.4.1 Withholding Timesp. 91
2.5.4.2 Prediction of Withdholding Times from Plasma Pharmacokinetic Datap. 93
2.5.4.3 International Tradep. 93
2.5.5 Risk Communicationp. 94
2.6 Residue Violations: Their Significance and Preventionp. 94
2.6.1 Roles of Regulatory and Non-regulatory Bodiesp. 94
2.6.2 Residue Detection Programsp. 95
2.6.2.1 Monitoring Programp. 96
2.6.2.2 Enforcement Programsp. 96
2.6.2.3 Surveillance Programsp. 97
2.6.2.4 Exploratory Programsp. 97
2.6.2.5 Imported Food Animal Productsp. 97
2.6.2.6 Residue Testing in Milkp. 97
2.7 Further Considerationsp. 98
2.7.1 Injection Site Residues and Flip-Flop Pharmacokineticsp. 98
2.7.2 Bioequivalence and Residue Depletion Profilesp. 100
2.7.3 Sales and Usage Datap. 101
2.7.3.1 Sales of AMDs in the United Kingdom, 2003-2008p. 101
2.7.3.2 Comparison of AMD Usage in Human and Veterinary Medicine in France, 1999-2005p. 102
2.7.3.3 Global Animal Health Sales and Sales of AMDs for Bovine Respiratory Diseasep. 103
Referencesp. 104
3 Antibiotic Residues in Food and Drinking Water, and Food Safety Regulationsp. 111
3.1 Introductionp. 111
3.2 Residues in Food-Where is the Smoking Gun?p. 111
3.3 How Allowable Residue Concentrations Are Determinedp. 113
3.3.1 Toxicology-Setting Concentrations Allowed in the Human Dietp. 113
3.3.2 Setting Residue Concentrations for Substances Not Allowed in Foodp. 114
3.3.3 Setting Residue Concentrations Allowed in Foodp. 114
3.3.3.1 Tolerancesp. 115
3.3.3.2 Maximum Residue Limitsp. 116
3.3.4 International Harmonizationp. 117
3.4 Indirect Consumer Exposure to Antibiotics in the Natural Environmentp. 117
3.4.1 Transport to and Occurrence in Surface Waters and Groundwatersp. 119
3.4.2 Uptake of Antibiotics into Cropsp. 119
3.4.3 Risks of Antibiotics in the Environment to Human Healthp. 120
3.5 Summaryp. 120
Referencesp. 121
4 Sample Preparation: Extraction and Clean-upp. 125
4.1 Introductionp. 125
4.2 Sample Selection and Pre-treatmentp. 126
4.3 Sample Extractionp. 127
4.3.1 Target Marker Residuep. 127
4.3.2 Stability of Biological Samplesp. 127
4.4 Extraction Techniquesp. 128
4.4.1 Liquid-Liquid Extractionp. 128
4.4.2 Dilute and Shootp. 128
4.4.3 Liquid-Liquid Based Extraction Proceduresp. 129
4.4.3.1 QuEChERSp. 129
4.4.3.2 Bipolarity Extractionp. 129
4.4.4 Pressurized Liquid Extraction (Including Supercritical Fluid Extraction)p. 130
4.4.5 Solid Phase Extraction (SPE)p. 131
4.4.5.1 Conventional SPEp. 131
4.4.5.2 Automated SPEp. 132
4.4.6 Solid Phase Extraction-Based Techniquesp. 133
4.4.6.1 Dispersive SPEp. 133
4.4.6.2 Matrix Solid Phase Dispersionp. 134
4.4.6.3 Solid Phase Micro-extractionp. 135
4.4.6.4 Micro-extraction by Packed Sorbentp. 137
4.4.6.5 Stir-bar Sorptive Extractionp. 137
4.4.6.6 Restricted-Access Materialsp. 138
4.4.7 Solid Phase Extraction-Based Selective Approachesp. 138
4.4.7.1 Immunoaffinity Chromatographyp. 138
4.4.7.2 Molecularly Imprinted Polymersp. 139
4.4.7.3 Aptamersp. 140
4.4.8 Turbulent-Flow Chromatographyp. 140
4.4.9 Miscellaneousp. 142
4.4.9.1 Ultrafiltrationp. 142
4.4.9.2 Microwave-Assisted Extractionp. 142
4.4.9.3 Ultrasound-Assisted Extractionp. 144
4.5 Final Remarks and Conclusionsp. 144
Referencesp. 146
5 Bioanalytical Screening Methodsp. 153
5.1 Introductionp. 153
5.2 Microbial Inhibition Assaysp. 154
5.2.1 The History and Basic Principles of Microbial Inhibition Assaysp. 154
5.2.2 The Four-Plate Test and the New Dutch Kidney Testp. 156
5.2.3 Commercial Microbial Inhibition Assays for Milkp. 156
5.2.4 Commercial Microbial Inhibition Assays for Meat-, Egg-, and Honey-Based Foodsp. 159
5.2.5 Further Developments of Microbial Inhibition Assays and Future Prospectsp. 160
5.2.5.1 Sensitivityp. 160
5.2.5.2 Test Durationp. 161
5.2.5.3 Ease of Usep. 161
5.2.5.4 Automationp. 161
5.2.5.5 Pre-treatment of Samplesp. 162
5.2.5.6 Confirmation/Class-Specific Identificationp. 163
5.2.6 Conclusions Regarding Microbial Inhibition Assaysp. 164
5.3 Rapid Test Kitsp. 164
5.3.1 Basic Principles of Immunoassay Format Rapid Testsp. 164
5.3.2 Lateral-Flow Immunoassaysp. 165
5.3.2.1 Sandwich Formatp. 166
5.3.2.2 Competitive Formatp. 166
5.3.3 Commercial Lateral-Flow Immunoassays for Milk, Animal Tissues, and Honeyp. 168
5.3.4 Receptor-Based Radioimmunoassay: Charm II Systemp. 170
5.3.5 Basic Principles of Enzymatic Testsp. 171
5.3.5.1 The Penzyme Milk Testp. 171
5.3.5.2 The Delvo-X-PRESSp. 172
5.3.6 Conclusions Regarding Rapid Test Kitsp. 174
5.4 Surface Plasmon Resonance (SPR) Biosensor Technologyp. 174
5.4.1 Basic Principles of SPR Biosensorp. 174
5.4.2 Commercially Available SPR Biosensor Applications for Milk, Animal Tissues, Feed, and Honeyp. 175
5.4.3 Conclusions Regarding Surface Plasmon Resonance (SPR) Technologyp. 176
5.5 Enzyme-Linked Immunosorbent Assay (ELISA)p. 178
5.5.1 Basic Principles of ELISAp. 178
5.5.2 Automated ELISA Systemsp. 178
5.5.3 Alternative Immunoassay Formatsp. 179
5.5.4 Commercially Available ELISA Kits for Antibiotic Residuesp. 179
5.5.5 Conclusions Regarding ELISAp. 180
5.6 General Considerations Concerning the Performance Criteria for Screening Assaysp. 181
5.7 Overall Conclusions on Bioanalytical Screening Assaysp. 181
Abbreviationsp. 182
Referencesp. 182
6 Chemical Analysis: Quantitative and Confirmatory Methodsp. 187
6.1 Introductionp. 187
6.2 Single-Class and Multi-class Methodsp. 187
6.3 Chromatographic Separationp. 195
6.3.1 Chromatographic Parametersp. 195
6.3.2 Mobile Phasep. 195
6.3.3 Conventional Liquid Chromatographyp. 196
6.3.3.1 Reversed Phase Chromatographyp. 196
6.3.3.2 Ion-Pairing Chromatographyp. 196
6.3.3.3 Hydrophilic Interaction Liquid Chromatographyp. 197
6.3.4 Ultra-High-Performance or Ultra-High-Pressure Liquid Chromatographyp. 198
6.4 Mass Spectrometryp. 200
6.4.1 Ionization and Interfacesp. 200
6.4.2 Matrix Effectsp. 202
6.4.3 Mass Spectrometersp. 205
6.4.3.1 Single Quadrupolep. 205
6.4.3.2 Triple Quadrupolep. 206
6.4.3.3 Quadrupole Ion Trapp. 208
6.4.3.4 Linear Ion Trapp. 209
6.4.3.5 Time-of-Flightp. 210
6.4.3.6 Orbitrapp. 212
6.4.4 Other Advanced Mass Spectrometric Techniquesp. 214
6.4.4.1 Ion Mobility Spectrometryp. 214
6.4.4.2 Ambient Mass Spectrometryp. 214
6.4.4.3 Other Recently Developed Desorption Ionization Techniquesp. 216
6.4.5 Fragmentationp. 216
6.4.6 Mass Spectral Libraryp. 216
Acknowledgmentp. 219
Abbreviationsp. 220
Referencesp. 220
7 Single-Residue Quantitative and Confirmatory Methodsp. 227
7.1 Introductionp. 227
7.2 Carbadox and Olaquindoxp. 227
7.2.1 Backgroundp. 227
7.2.2 Analysisp. 229
7.2.3 Conclusionsp. 230
7.3 Ceftiofur and Desfuroylceftiofurp. 230
7.3.1 Backgroundp. 230
7.3.2 Analysis Using Deconjugationp. 231
7.3.3 Analysis of Individual Metabolitesp. 232
7.3.4 Analysis after Alkaline Hydrolysisp. 232
7.3.5 Conclusionsp. 233
7.4 Chloramphenicolp. 233
7.4.1 Backgroundp. 233
7.4.2 Analysis by GC-MS and LC-MSp. 233
7.4.3 An Investigation into the Possible Natural Occurrence of CAPp. 235
7.4.4 Analysis of CAP in Herbs and Grass (Feed) Using LC-MSp. 236
7.4.5 Conclusionsp. 236
7.5 Nitrofuransp. 236
7.5.1 Backgroundp. 236
7.5.2 Analysis of Nitrofuransp. 236
7.5.3 Identification of Nitrofuran Metabolitesp. 237
7.5.4 Conclusionsp. 239
7.6 Nitroimidazoles and Their Metabolitesp. 239
7.6.1 Backgroundp. 239
7.6.2 Analysisp. 240
7.6.3 Conclusionsp. 241
7.7 Sulfonamides and Their N4-Acetyl Metabolitesp. 241
7.7.1 Backgroundp. 241
7.7.2 N4-Acetyl Metabolitesp. 242
7.7.3 Analysisp. 243
7.7.4 Conclusionsp. 244
7.8 Tetracyclines and Their 4-Epimersp. 244
7.8.1 Backgroundp. 244
7.8.2 Analysisp. 245
7.8.3 Conclusionsp. 246
7.9 Miscellaneousp. 246
7.9.1 Aminoglycosidesp. 246
7.9.2 Compounds with Marker Residues Requiring Chemical Conversionp. 247
7.9.2.1 Florfenicolp. 247
7.9.3 Miscellaneous Analytical Issuesp. 250
7.9.3.1 Lincosamidesp. 250
7.9.3.2 Enrofloxacinp. 251
7.9.4 Gaps in Analytical Coveragep. 251
7.10 Summaryp. 252
Abbreviationsp. 253
Referencesp. 254
8 Method Development and Method Validationp. 263
8.1 Introductionp. 263
8.2 Sources of Guidance on Method Validationp. 263
8.2.1 Organizations that Are Sources of Guidance on Method Validationp. 264
8.2.1.1 International Union of Pure and Applied Chemistry (IUPAC)p. 264
8.2.1.2 AOAC Internationalp. 264
8.2.1.3 International Standards Organization (ISO)p. 264
8.2.1.4 Eurachemp. 265
8.2.1.5 VICHp. 265
8.2.1.6 Codex Alimentarius Commission (CAC)p. 265
8.2.1.7 Joint FAO/WHO Expert Committee on Food Additives (JECFA)p. 265
8.2.1.8 European Commissionp. 266
8.2.1.9 US Food and Drug Administration (USFDA)p. 266
8.3 The Evolution of Approaches to Method Validation for Veterinary Drug Residues in Foodsp. 266
8.3.1 Evolution of "Single-Laboratory Validation" and the "Criteria Approach,"p. 266
8.3.2 The Vienna Consultationp. 267
8.3.3 The Budapest Workshop and the Miskolc Consultationp. 267
8.3.4 Codex Alimentarius Commission Guidelinesp. 267
8.4 Method Performance Characteristicsp. 268
8.5 Components of Method Developmentp. 268
8.5.1 Identification of "Fitness for Purpose" of an Analytical Methodp. 269
8.5.2 Screening versus Confirmationp. 270
8.5.3 Purity of Analytical Standardsp. 270
8.5.4 Analyte Stability in Solutionp. 271
8.5.5 Planning the Method Developmentp. 271
8.5.6 Analyte Stability during Sample Processing (Analysis)p. 272
8.5.7 Analyte Stability during Sample Storagep. 272
8.5.8 Ruggedness Testing (Robustness)p. 273
8.5.9 Critical Control Pointsp. 274
8.6 Components of Method Validationp. 274
8.6.1 Understanding the Requirementsp. 274
8.6.2 Management of the Method Validation Processp. 274
8.6.3 Experimental Designp. 275
8.7 Performance Characteristics Assessed during Method Development and Confirmed during Method Validation for Quantitative Methodsp. 275
8.7.1 Calibration Curve and Analytical Rangep. 275
8.7.2 Sensitivityp. 277
8.7.3 Selectivityp. 277
8.7.3.1 Definitionsp. 277
8.7.3.2 Suggested Selectivity Experimentsp. 278
8.7.3.3 Additional Selectivity Considerations for Mass Spectral Detectionp. 279
8.7.4 Accuracyp. 281
8.7.5 Recoveryp. 282
8.7.6 Precisionp. 283
8.7.7 Experimental Determination of Recovery and Precisionp. 283
8.7.7.1 Choice of Experimental Designp. 283
8.7.7.2 Matrix Issues in Calibrationp. 286
8.7.8 Measurement Uncertainty (MU)p. 287
8.7.9 Limits of Detection and Limits of Quantificationp. 287
8.7.10 Decision Limit (CCa) and Detection Capability (CCß)p. 289
8.8 Significant Figuresp. 289
8.9 Final Thoughtsp. 289
Referencesp. 289
9 Measurement Uncertaintyp. 295
9.1 Introductionp. 295
9.2 General Principles and Approachesp. 295
9.3 Worked Examplesp. 297
9.3.1 EURACHEM/CITAC Approachp. 297
9.3.2 Measurement Uncertainty Based on the Barwick-Ellison Approach Using In-House Validation Datap. 302
9.3.3 Measurement Uncertainty Based on Nested Experimental Design Using In-House Validation Datap. 305
9.3.3.1 Recovery (R) and Its Uncertainty [u(R)]p. 306
9.3.3.2 Precision and Its Uncertainty [u(P )]p. 312
9.3.3.3 Combined Standard Uncertainty and Expanded Uncertaintyp. 312
9.3.4 Measurement Uncertainty Based on Inter-laboratory Study Datap. 312
9.3.5 Measurement Uncertainty Based on Proficiency Test Datap. 317
9.3.6 Measurement Uncertainty Based on Quality Control Data and Certified Reference Materialsp. 319
9.3.6.1 Scenario A: Use of Certified Reference Material for Estimation of Uncertaintyp. 320
9.3.6.2 Scenario B. Use of Incurred Residue Samples and Fortified Blank Samples for Estimation of Uncertaintyp. 324
Referencesp. 325
10 Quality Assurance and Quality Controlp. 327
10.1 Introductionp. 327
10.1.1 Quality-What Is It?p. 327
10.1.2 Why Implement a Quality System?p. 328
10.1.3 Quality System Requirements for the Laboratoryp. 328
10.2 Quality Managementp. 329
10.2.1 Total Quality Managementp. 329
10.2.2 Organizational Elements of a Quality Systemp. 330
10.2.2.1 Process Managementp. 330
10.2.2.2 The Quality Manualp. 330
10.2.2.3 Documentationp. 330
10.2.3 Technical Elements of a Quality Systemp. 331
10.3 Conformity Assessmentp. 331
10.3.1 Audits and Inspectionsp. 331
10.3.2 Certification and Accreditationp. 332
10.3.3 Advantages of Accreditationp. 332
10.3.4 Requirements under Codex Guidelines and EU Legislationp. 332
10.4 Guidelines and Standardsp. 333
10.4.1 Codex Alimentariusp. 333
10.4.2 Guidelines for the Design and Implementation of a National Regulatory Food Safety Assurance Program Associated with the Use of Veterinary Drugs in Food-Producing Animalsp. 334
10.4.3 ISO/IEC 17025:2005p. 334
10.4.4 Method Validation and Quality Control Procedures for Pesticide Residue Analysis in Food and Feed (Document SANCO/10684/2009)p. 335
10.4.5 EURACHEM/CITAC Guide to Quality in Analytical Chemistryp. 335
10.4.6 OECD Good Laboratory Practicep. 336
10.5 Quality Control in the Laboratoryp. 336
10.5.1 Sample Reception, Storage, and Traceability throughout the Analytical Processp. 336
10.5.1.1 Sample Receptionp. 336
10.5.1.2 Sample Acceptancep. 337
10.5.1.3 Sample Identificationp. 337
10.5.1.4 Sample Storage (Pre-analysis)p. 337
10.5.1.5 Reportingp. 338
10.5.1.6 Sample Documentationp. 338
10.5.1.7 Sample Storage (Post-reporting)p. 338
10.5.2 Analytical Method Requirementsp. 338
10.5.2.1 Introductionp. 338
10.5.2.2 Screening Methodsp. 338
10.5.2.3 Confirmatory Methodsp. 339
10.5.2.4 Decision Limit, Detection Capability, Performance Limit, and Sample Compliancep. 339
10.5.3 Analytical Standards and Certified Reference Materialsp. 339
10.5.3.1 Introductionp. 339
10.5.3.2 Certified Reference Materials (CRMs)p. 340
10.5.3.3 Blank Samplesp. 341
10.5.3.4 Utilization of CRMs and Control Samplesp. 341
10.5.4 Proficiency Testing (PT)p. 341
10.5.5 Control of Instruments and Methods in the Laboratoryp. 342
10.6 Conclusionp. 344
Referencesp. 344
Indexp. 347